Literatur
Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii10–iii20
Salati SA, Al Kadi A (2012) Anal cancer – a review. Int J Health Sci (qassim) 6(2):206–230
Garrett K, Kalady MF (2010) Anal neoplasms. Surg Clin North Am 90(1):147–161
Fraunholz I, Woeste G, Hofheinz RD (2014) Therapie des Analkarzinoms. Onkologe 20(2):173–182
Nigro ND, Vaitkevicius VK, Considine B Jr. (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17(3):354–356
National Comprehensive Cancer Network NCCN (2017) Clinical practice guidelines in oncology, anal carcinoma. Version I. http://www.nccn.org (Erstellt: 23. Nov. 2016). Zugegriffen: 22. Jan. 2017
Deutsche Aids-Gesellschaft e. V. (DAIG) (2013) Deutsch-Österreichische Leitlinie: Anale Dysplasien und Analkarzinome bei HIV-Infizierten: Prävention, Diagnostik, Therapie. http://www.awmf.org/uploads/tx_szleitlinien/055-007l_S1k_Anale_Dysplasien_Analkarzinom_HIV_infizierten_09-2013__01.pdf. Zugegriffen: 8. Apr. 2016
James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial. Lancet Oncol 14(6):516–524
Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett C (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299(16):1914–1921
Peiffert D, Tournier-Rangeard L, Gérard JP, Lemanski C, François E, Giovannini M, Cvitkovic F, Mirabel X, Bouché O, Luporsi E, Conroy T, Montoto-Grillot C, Mornex F, Lusinchi A, Hannoun-Lévi JM, Seitz JF, Adenis A, Hennequin C, Denis B, Ducreux M (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol 30(16):1941–1948
Glynne-Jones R, Saleem W, Harrison M, Mawdsley S, Hall M (2016) Background and current treatment of squamous cell carcinoma of the anus. Oncol Ther 4(2):135–172
Harris DA, Williamson J, Davies M, Evans MD, Drew P, Beynon J, Swansea Pelvic Oncology Group (2013) Outcome of salvage surgery for anal squamous cell carcinoma. Colorectal Dis 15(8):968–973
NCCN (2017) Guidlines version 2/2017 anal carcinoma. www.nccn.org/professionals/physician_gls/PDF/anal.pdf. Zugegriffen: 15. Nov. 2017
Siewert JR, Rothmund M, Schumpelick V (2010) Praxis der Viszeralchirurgie. Onkologische Chirurgie. In: Zimmermann F, Tympner Ch (Hrsg) Analkarzinom, 3. Aufl. Springer, Berlin, Heidelberg, S 735–731
Raptis D, Scheider I, Matzel KE, Ott O, Fietkau R, Hohenberger W (2015) Differenzialdiagnose und interdisziplinäre Therapie des Analkarzinoms. Dtsch Arztebl 112(14):243–248
Otto SD, Lee L, Buhr HJ et al (2009) Staging anal cancer: prospective comparison of transanal endoscopic ultrasound and magnetic resonance imaging. J Gastrointest Surg 13:1292–1298
Glynne-Jones R, Nilsson PJ, Aschele C et al (2014) Anal cancer. ESMO-ESSO-ESTRO clinical practice guidelines fpr diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):10–20
Harris DA, Williamson J, Davies M, Evans MD, Drew P, Beynon J, Swansea Pelvic Oncology Group (2013) Outcome of salvage surgery for anal squamous cell carcinoma. Colorectal Dis 15(8):68–73
Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354–356
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Interessenkonflikt
H. Dralle, K. Kols, H. Witzigmann und R. Viebahn geben an, dass kein Interessenkonflikt besteht.
Rights and permissions
About this article
Cite this article
Dralle, H., Kols, K., Witzigmann, H. et al. Primärtherapie des Analkarzinoms. Chirurg 89, 152–154 (2018). https://doi.org/10.1007/s00104-017-0573-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00104-017-0573-2